characterisation of a potent and selective GPR 139 agonist radioligand †

Department of Drug Design and Pharma Sciences, University of Copenhagen, Denma Amsterdam Institute for Molecules, Medic Medicinal Chemistry, Faculty of Science, V 1083, 1081 HV Amsterdam, The Netherland Institute of Organic Chemistry and Biochem Republic, 16610, Prague 6, Czech Republic † Electronic supplementary information reductive debromination reactions characterisation of all compounds. Detai assays, clog P and log S calculations. See ‡ These authors contributed equally. Cite this: RSC Adv., 2016, 6, 947